Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NCT07670897 GZR-4 Diabetes Mellitus, Type 2 Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07670897 clinical trial report covering GZR-4, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20262441 Rifampin Endometriosis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262441 clinical trial report covering Rifampin, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20262410 Human Growth Hormone(Yifan Pharmaceutical) Growth Disorders Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262410 clinical trial report covering Human Growth Hormone(Yifan Pharmaceutical), Phase 1, endpoints, sponsor, geography, readout timing and developme
Latest Hotspot
8 min read
CTR20262407 YR-001 Dermatitis, Atopic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262407 clinical trial report covering YR-001, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20262510 YOLT-203 Primary Hyperoxaluria Type 1 Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262510 clinical trial report covering YOLT-203, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20262319 HJ178 Diabetes Mellitus, Type 2 Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262319 clinical trial report covering HJ178, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20262522 HRN77 Depressive Disorder Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262522 clinical trial report covering HRN77, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20262488 LPM-3770164 Huntington Disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262488 clinical trial report covering LPM-3770164, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07672756 PJ-008 Phenylketonurias Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07672756 clinical trial report covering PJ-008, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07673068 Recombinant Hepatitis B Therapeutic Vaccine(Grand Theravac Life) Hepatitis B, Chronic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07673068 clinical trial report covering Recombinant Hepatitis B Therapeutic Vaccine(Grand Theravac Life), Phase 1, endpoints, sponsor, geography, readou
Latest Hotspot
8 min read
NCT07673601 ARGX-119 Herpesviridae Infections Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07673601 clinical trial report covering ARGX-119, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07673900 Semaglutide (Terrestrial) Obesity Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07673900 clinical trial report covering Semaglutide (Terrestrial), Phase 1, endpoints, sponsor, geography, readout timing and development white space.